$ALT
Altimmune, Inc.

2015 Q4 Form 10-K Financial Statement

#000114420416087617 Filed on March 11, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2015 2014 Q4
Revenue $1.270M $10.64M $1.830M
YoY Change -30.6% 4.42% -49.86%
Cost Of Revenue -$50.00K -$50.00K
YoY Change
Gross Profit $1.320M $10.69M
YoY Change
Gross Profit Margin 103.94% 100.47%
Selling, General & Admin $980.0K $6.220M $2.620M
YoY Change -62.6% -42.99% -42.79%
% of Gross Profit 74.24% 58.19%
Research & Development $1.170M $5.134M $1.790M
YoY Change -34.64% -44.92% -56.34%
% of Gross Profit 88.64% 48.02%
Depreciation & Amortization $30.00K $141.6K $40.00K
YoY Change -25.0% -5.57% 0.0%
% of Gross Profit 2.27% 1.32%
Operating Expenses $2.180M $14.04M $4.450M
YoY Change -51.01% -31.1% -48.97%
Operating Profit -$940.5K -$3.403M -$2.624M
YoY Change -64.15% -66.61% -48.23%
Interest Expense -$280.0K $54.58K $10.00K
YoY Change -2900.0% -74.06% -98.48%
% of Operating Profit
Other Income/Expense, Net $0.00 $23.84K $0.00
YoY Change -91.99%
Pretax Income -$1.220M -$3.379M -$2.620M
YoY Change -53.44% -65.85% -40.59%
Income Tax $20.00K $61.75K $10.00K
% Of Pretax Income
Net Earnings -$1.238M -$3.441M -$2.629M
YoY Change -52.9% -65.44% -40.57%
Net Earnings / Revenue -97.51% -32.34% -143.68%
Basic Earnings Per Share -$0.02 -$0.05 -$0.04
Diluted Earnings Per Share -$0.02 -$0.05 -$0.04
COMMON SHARES
Basic Shares Outstanding 64.45M shares 63.99M shares 63.37M shares
Diluted Shares Outstanding 63.99M shares

Balance Sheet

Concept 2015 Q4 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.60M $15.60M $18.60M
YoY Change -16.13% -16.13% 77.14%
Cash & Equivalents $15.57M $9.100M $18.64M
Short-Term Investments $6.400M $6.400M $6.400M
Other Short-Term Assets $200.0K $200.0K $200.0K
YoY Change 0.0% 0.0% 0.0%
Inventory
Prepaid Expenses
Receivables $1.500M $1.500M $400.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.23M $17.20M $19.25M
YoY Change -10.51% -10.88% 34.25%
LONG-TERM ASSETS
Property, Plant & Equipment $233.7K $200.0K $325.8K
YoY Change -28.26% -33.33% -15.62%
Goodwill $22.49M $2.348M
YoY Change 857.85% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $53.38K $100.0K $53.38K
YoY Change 0.0% 0.0% -18.7%
Total Long-Term Assets $2.636M $2.700M $2.728M
YoY Change -3.38% 0.0% -2.59%
TOTAL ASSETS
Total Short-Term Assets $17.23M $17.20M $19.25M
Total Long-Term Assets $2.636M $2.700M $2.728M
Total Assets $19.86M $19.90M $21.98M
YoY Change -9.63% -9.55% 28.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $521.1K $500.0K $391.4K
YoY Change 33.14% 25.0% -65.31%
Accrued Expenses $1.600M $1.500M $1.200M
YoY Change 33.33% 36.36% -62.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $746.1K
YoY Change -100.0% -100.0% -25.39%
Total Short-Term Liabilities $2.179M $2.200M $2.582M
YoY Change -15.58% -15.38% -62.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $433.4K $1.000M $493.1K
YoY Change -12.11% -9.09% -16.24%
Total Long-Term Liabilities $433.4K $1.000M $493.1K
YoY Change -12.11% -9.09% -62.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.179M $2.200M $2.582M
Total Long-Term Liabilities $433.4K $1.000M $493.1K
Total Liabilities $3.213M $3.200M $3.704M
YoY Change -13.25% -13.51% -62.22%
SHAREHOLDERS EQUITY
Retained Earnings -$223.7M -$220.3M
YoY Change 1.56% 4.73%
Common Stock $6.438K $238.8M
YoY Change -100.0% 9.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.13M $16.60M $18.27M
YoY Change
Total Liabilities & Shareholders Equity $19.86M $19.90M $21.98M
YoY Change -9.63% -9.55% 28.23%

Cashflow Statement

Concept 2015 Q4 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$1.238M -$3.441M -$2.629M
YoY Change -52.9% -65.44% -40.57%
Depreciation, Depletion And Amortization $30.00K $141.6K $40.00K
YoY Change -25.0% -5.57% 0.0%
Cash From Operating Activities -$1.830M -$3.220M -$3.520M
YoY Change -48.01% -61.98% -43.77%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $86.51K $0.00
YoY Change -6.24%
Acquisitions
YoY Change
Other Investing Activities $0.00 $10.00K $0.00
YoY Change 0.0%
Cash From Investing Activities -$20.00K -$80.00K $0.00
YoY Change 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $973.1K
YoY Change -94.64%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 220.0K 2.550M
YoY Change -98.82% -98.68% 222.78%
NET CHANGE
Cash From Operating Activities -1.830M -3.220M -3.520M
Cash From Investing Activities -20.00K -80.00K 0.000
Cash From Financing Activities 30.00K 220.0K 2.550M
Net Change In Cash -1.820M -3.080M -970.0K
YoY Change 87.63% -137.65% -82.27%
FREE CASH FLOW
Cash From Operating Activities -$1.830M -$3.220M -$3.520M
Capital Expenditures -$20.00K $86.51K $0.00
Free Cash Flow -$1.810M -$3.307M -$3.520M
YoY Change -48.58% -61.38% -43.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Goodwill
Goodwill
2348453 USD
CY2014Q4 us-gaap Goodwill
Goodwill
2348453 USD
CY2015Q4 us-gaap Assets
Assets
19862397 USD
CY2014Q4 us-gaap Assets
Assets
21978241 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
521122 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
391396 USD
CY2015Q4 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1248708 USD
CY2014Q4 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1195412 USD
CY2015Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
381950 USD
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
81000000 USD
CY2015 dei Trading Symbol
TradingSymbol
PIP
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65251230 shares
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15569813 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18643351 USD
CY2015Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
511994 USD
CY2014Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
110656 USD
CY2015Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
963345 USD
CY2014Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
297431 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
181714 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
199194 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
17226866 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
19250632 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
233694 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
325772 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53384 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53384 USD
CY2014Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
746146 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11250 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
70326 USD
CY2015Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
16411 USD
CY2014Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
178509 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2179441 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2581789 USD
CY2015Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
108641 USD
CY2014Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
0 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
433407 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
493137 USD
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
491791 USD
CY2014Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
629170 USD
CY2015Q4 us-gaap Liabilities
Liabilities
3213280 USD
CY2014Q4 us-gaap Liabilities
Liabilities
3704096 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
6438 USD
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001326190
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Entity Registrant Name
EntityRegistrantName
PHARMATHENE, INC
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3378959 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61746 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61746 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-11718353 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1382 USD
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
336 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
61746 USD
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
-45358 USD
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
7600 USD
CY2013 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
2546159 USD
CY2014 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2013 us-gaap Depreciation
Depreciation
182487 USD
CY2015 us-gaap Depreciation
Depreciation
141604 USD
CY2014 us-gaap Depreciation
Depreciation
149958 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
28751815 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-9955395 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
6360 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
240366704 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
238780633 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-223724025 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220283320 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-229528 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
16649117 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
18274145 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19862397 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21978241 USD
CY2013 us-gaap Contracts Revenue
ContractsRevenue
17912607 USD
CY2015 us-gaap Contracts Revenue
ContractsRevenue
10640660 USD
CY2014 us-gaap Contracts Revenue
ContractsRevenue
10190205 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15290142 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5133512 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9319828 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13279186 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6222185 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10911724 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
14043460 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
20381510 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-10839208 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-3402800 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-10191305 USD
CY2013 us-gaap Interest Expense
InterestExpense
366706 USD
CY2015 us-gaap Interest Expense
InterestExpense
54581 USD
CY2014 us-gaap Interest Expense
InterestExpense
210399 USD
CY2013 pip Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
0 USD
CY2015 pip Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
229192 USD
CY2014 pip Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
0 USD
CY2013 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-444622 USD
CY2015 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
299477 USD
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
508817 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6071 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8137 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-762 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-817399 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23841 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
297656 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11656607 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9893649 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61746 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-3440705 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50659116 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63986013 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57535325 shares
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10818 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-229192 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11719735 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3211177 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9966213 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
613017 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1655647 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
61746 USD
CY2014 us-gaap Paid In Kind Interest
PaidInKindInterest
83021 USD
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5394 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
401338 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1316457 USD
CY2015 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
665914 USD
CY2014 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-1902094 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5202 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5367 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
129726 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-736776 USD
CY2015 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
481761 USD
CY2014 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
0 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-54818 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2089493 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-341723 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3215981 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8474042 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
86507 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92269 USD
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7600 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-78907 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-84269 USD
CY2015 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-750007 USD
CY2014 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-999996 USD
CY2015 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
CY2014 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1091740 USD
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
683325 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
973132 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18141935 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
223125 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
16733524 USD
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1775 USD
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-12841 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3073538 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8162372 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10480979 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1362716 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64382086 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63603303 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64382086 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63603303 shares
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1362716 USD
CY2013 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-238767 USD
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6018891 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5030127 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1382 USD
CY2015 us-gaap Interest Paid
InterestPaid
108391 USD
CY2014 us-gaap Interest Paid
InterestPaid
128073 USD
CY2015Q4 pip Billed And Unbilled Accounts Receivable Net
BilledAndUnbilledAccountsReceivableNet
1500000 USD
CY2015Q4 pip Additional Common Stock Aggregate Gross Sales
AdditionalCommonStockAggregateGrossSales
3000000 USD
CY2015Q4 pip Maximum Amount Of Reimbursement
MaximumAmountOfReimbursement
210000 USD
CY2015Q4 pip Annual License Payment
AnnualLicensePayment
200000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
613017 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1655647 USD
CY2015 pip Share Based Compensation Extension Of Exercise Period
ShareBasedCompensationExtensionOfExercisePeriod
75000 USD
CY2015 pip Share Based Compensation Reversal From Stock Option Forfeitures
ShareBasedCompensationReversalFromStockOptionForfeitures
129000 USD
CY2015 pip Share Based Compensation Reversal Net
ShareBasedCompensationReversalNet
53741 USD
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6500000 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11900000 shares
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
36981 USD
CY2015Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
0 USD
CY2015Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
250128 USD
CY2015Q4 us-gaap Accrued Rent Noncurrent
AccruedRentNoncurrent
108641 USD
CY2015 pip Warrant Expiration Date
WarrantExpirationDate
2015-01-28
CY2015Q1 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
194600000 USD
CY2015Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
113100000 USD
CY2015Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
81500000 USD
CY2015Q3 pip Maximum Amount Of Reimbursement
MaximumAmountOfReimbursement
210000 USD
CY2015Q3 pip Annual License Payment
AnnualLicensePayment
200000 USD
CY2015Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1422781 shares
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
61746 USD
CY2013 us-gaap Paid In Kind Interest
PaidInKindInterest
135162 USD
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3500 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1005528 USD
CY2013 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-1914917 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-282057 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-569120 USD
CY2013 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
0 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
773566 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1040032 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7168204 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
84579 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3500 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-81079 USD
CY2013 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-749997 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2220538 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12701517 USD
CY2013 us-gaap Interest Paid
InterestPaid
234119 USD
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Use of Estimates</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our consolidated financial statements include significant estimates for the expected economic life and value of our tangible assets and value of our indefinite lived intangible asset, the amount of our net operating losses, our share-based compensation, and financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
8900 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1649994 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
455840 USD
CY2014 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
5653 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
11673840 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5944095 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1352117 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
74796 USD
CY2013 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
10599 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
7335712 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17686095 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
613017 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
973132 USD
CY2014 pip Shares Issued Upon Exercise Of Warrants
SharesIssuedUponExerciseOfWarrants
1107064 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1857256 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2188703 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2090950 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2514475 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
451805 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
540722 USD
CY2015Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
600390 USD
CY2014Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
509953 USD
CY2015Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
102632 USD
CY2014Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
37313 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
93881 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
107424 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
65635003 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
64361842 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
61590084 USD
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
139853 USD
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
166205 USD
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
148395 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3834 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1726 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2352660 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
6909 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-6274 USD
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-2706156 USD
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
68482 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3458334 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3368571 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
91210 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
366797 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
859358 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
68227626 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
68357012 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
65968134 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2013Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2015Q4 pip Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
68227626 USD
CY2014Q4 pip Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
68357012 USD
CY2013Q4 pip Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
65968134 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
68608401 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
68676033 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66225409 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
380775 USD
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
319021 USD
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
257275 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1148846 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3363841 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3963246 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-124626 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-450656 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1179476 USD
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
7913 USD
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-710512 USD
CY2015 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1218 USD
CY2014 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
794807 USD
CY2013 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-369407 USD
CY2015 pip Lobbying Costs
LobbyingCosts
1047 USD
CY2014 pip Lobbying Costs
LobbyingCosts
57517 USD
CY2013 pip Lobbying Costs
LobbyingCosts
98507 USD
CY2015 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
-1049765 USD
CY2014 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
-380689 USD
CY2013 us-gaap Income Tax Reconciliation Deductions Other
IncomeTaxReconciliationDeductionsOther
0 USD
CY2015 pip Income Tax Reconciliation Limitation Deferred Write Off
IncomeTaxReconciliationLimitationDeferredWriteOff
0 USD
CY2014 pip Income Tax Reconciliation Limitation Deferred Write Off
IncomeTaxReconciliationLimitationDeferredWriteOff
0 USD
CY2013 pip Income Tax Reconciliation Limitation Deferred Write Off
IncomeTaxReconciliationLimitationDeferredWriteOff
6246942 USD
CY2015 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2949 USD
CY2014 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-308 USD
CY2013 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-1816 USD
CY2015 pip Income Tax Expense Benefit Before Change In Valuation Allowance
IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance
-143102 USD
CY2014 pip Income Tax Expense Benefit Before Change In Valuation Allowance
IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance
-2580153 USD
CY2013 pip Income Tax Expense Benefit Before Change In Valuation Allowance
IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance
-2585164 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
204848 USD
CY2013 us-gaap Maintenance Costs
MaintenanceCosts
40000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.86 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2014Q3 us-gaap Contracts Revenue
ContractsRevenue
962451 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2401866 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1169871 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3996030 USD
CY2014Q4 us-gaap Contracts Revenue
ContractsRevenue
1826296 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2623538 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-2258440 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-439120 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2641899 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2646910 USD
CY2015Q1 us-gaap Contracts Revenue
ContractsRevenue
7068746 USD
CY2015Q2 us-gaap Contracts Revenue
ContractsRevenue
1149570 USD
CY2015Q3 us-gaap Contracts Revenue
ContractsRevenue
1155839 USD
CY2015Q4 us-gaap Contracts Revenue
ContractsRevenue
1266505 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1161084 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1964867 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1658548 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-940469 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
1463395 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-2340932 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-1324768 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-1238400 USD
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2014Q1 us-gaap Contracts Revenue
ContractsRevenue
3742525 USD
CY2014Q2 us-gaap Contracts Revenue
ContractsRevenue
3658933 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-4628435 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-2629400 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
508202 USD
CY2015Q3 pip Initial Fund Value
InitialFundValue
5200000 USD
CY2015Q3 pip Additional Fund Value
AdditionalFundValue
4900000 USD
CY2015Q3 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
28100000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
400000 USD
CY2015Q1 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
2000000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
848273 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
356911 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1205184 USD
CY2015 us-gaap License Costs
LicenseCosts
300000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.7 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.84 pure
CY2013 us-gaap Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
0.5 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y1M6D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2015 us-gaap Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
0.5 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0150 pure
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
800000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0151 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0225 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0096 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0190 pure
CY2015 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
2546159 USD
CY2015 us-gaap Payments For Restructuring
PaymentsForRestructuring
2050830 USD
CY2015 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
4738 USD
CY2015Q4 us-gaap Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
490591 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11600000 shares
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
500000 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 USD
CY2013 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
20000 USD
CY2014 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
0 USD
CY2015 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
0 USD
CY2013Q1 pip Common Stock Aggregate Amount Equity Offering
CommonStockAggregateAmountEquityOffering
15000000 USD
CY2015 pip Stock Sales Agent Commission Percentage
StockSalesAgentCommissionPercentage
0.030 pure
CY2015Q4 pip Equity Offering Remaining Aggregate Sales Available
EquityOfferingRemainingAggregateSalesAvailable
3000000 USD
CY2014 pip Offering Costs In Connection With Controlled Equity Offering Sales Agreement
OfferingCostsInConnectionWithControlledEquityOfferingSalesAgreement
100000 USD
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Concentration of Credit Risk</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>&#160;</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial instruments that potentially subject us to concentrations of credit risk are primarily cash and cash equivalents, and billed and unbilled accounts receivable. We maintain our cash and cash equivalents in the form of money market accounts and overnight deposits with financial institutions that we believe are credit worthy. Because our billed and unbilled accounts receivable consist of amounts due from the U.S. Government, there is minimal credit risk.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4495556 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
700000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1300000 USD
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
800000 USD
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2015 pip Restructuring Expense Related To Property And Equipment
RestructuringExpenseRelatedToPropertyAndEquipment
36981 USD
CY2014 pip Restructuring Expense Related To Property And Equipment
RestructuringExpenseRelatedToPropertyAndEquipment
0 USD
CY2013 pip Restructuring Expense Related To Property And Equipment
RestructuringExpenseRelatedToPropertyAndEquipment
0 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
700000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
800000 USD
CY2015 us-gaap Maintenance Costs
MaintenanceCosts
100000 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5620128 shares
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 USD
CY2014 us-gaap Maintenance Costs
MaintenanceCosts
100000 USD
CY2015 pip Percentage Of Common Stock Delivered
PercentageOfCommonStockDelivered
1 pure
CY2015Q4 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
205000000 USD
CY2015Q1 us-gaap Government Contract Receivable Progess Payments Offset
GovernmentContractReceivableProgessPaymentsOffset
5800000 USD
CY2015 pip Operating Lease Term
OperatingLeaseTerm
P10Y
CY2015 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
200000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.13
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.30
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.23
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 USD
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
800000 USD
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1400000 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1400000 USD
CY2014Q2 pip Common Stock Aggregate Amount Equity Offering
CommonStockAggregateAmountEquityOffering
15000000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0225 pure
CY2015Q4 pip Beneficial Ownership Percentage Held By Affiliates
BeneficialOwnershipPercentageHeldByAffiliates
0.0499 pure

Files In Submission

Name View Source Status
0001144204-16-087617-index-headers.html Edgar Link pending
0001144204-16-087617-index.html Edgar Link pending
0001144204-16-087617.txt Edgar Link pending
0001144204-16-087617-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pip-20151231.xml Edgar Link completed
pip-20151231.xsd Edgar Link pending
pip-20151231_cal.xml Edgar Link unprocessable
pip-20151231_def.xml Edgar Link unprocessable
pip-20151231_lab.xml Edgar Link unprocessable
pip-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg28.jpg Edgar Link pending
v433058_10k.htm Edgar Link pending
v433058_ex10-3013.htm Edgar Link pending
v433058_ex21.htm Edgar Link pending
v433058_ex23.htm Edgar Link pending
v433058_ex31-1.htm Edgar Link pending
v433058_ex31-2.htm Edgar Link pending
v433058_ex32-1.htm Edgar Link pending
v433058_ex32-2.htm Edgar Link pending